MAP2K7 and acute myeloid leukemia: Our data suggest that RAB27B promotes AML cell growth by regulating NRAS/MEK/ERK signaling, therefore, we next interrogated data from BeatAML (44) to assess if RAB27B expression correlates with responses to MEK inhibitors (MEKi).